113 related articles for article (PubMed ID: 4370878)
41. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
Liu YX
Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):337-9. PubMed ID: 6317314
[No Abstract] [Full Text] [Related]
42. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
[TBL] [Abstract][Full Text] [Related]
43. Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers.
Henderson BE; Louie E; Bogdanoff E; Henie W; Alena B; Henie G
Cancer Res; 1974 May; 34(5):1207-10. PubMed ID: 4366990
[No Abstract] [Full Text] [Related]
44. Malaria antibody levels in patients with nasopharyngeal carcinoma.
Yadav M; Prasad U
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
[TBL] [Abstract][Full Text] [Related]
45. [Tumour-specific antibodies in the regional lymph nodes of patients with lung cancer (author's transl)].
Matsubara Y; Funatsu T; Hatakenaka R; Kuwabara M; Taki T; Miyamoto Y; Kosaba S; Ninomiya K; Ikeda S
Prax Klin Pneumol; 1980 Sep; 34(9):524-32. PubMed ID: 6256724
[No Abstract] [Full Text] [Related]
46. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
Yomi J; Fouda A; Fossi A; Bejanga B
Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568
[No Abstract] [Full Text] [Related]
47. In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity.
Brandes LJ; Goldenberg GJ
Cancer Res; 1974 Nov; 34(11):3095-101. PubMed ID: 4371172
[No Abstract] [Full Text] [Related]
48. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
[TBL] [Abstract][Full Text] [Related]
49. Demonstration of Epstein-Barr virus antibodies in serum of patients with nasopharyngeal carcinoma.
Kumar S; Wairagkar NS; Mahanta J
Indian J Cancer; 2001; 38(2-4):72-5. PubMed ID: 12593442
[TBL] [Abstract][Full Text] [Related]
50. [Detection of early NPC from VCA/IgA antibody positive individuals with anticomplement immunoenzymatic method].
Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):254-5. PubMed ID: 6295651
[No Abstract] [Full Text] [Related]
51. Evaluation and management of nasopharyngeal carcinoma.
Breen DL; Blair PA
J La State Med Soc; 1988 Feb; 140(2):16-7, 21. PubMed ID: 2831295
[No Abstract] [Full Text] [Related]
52. Anticomplement immunoenzymatic method of detecting Epstein-Barr nuclear antigen in nasopharyngeal carcinoma cells and normal epithelial cells.
Zeng Y; Shen SJ; Pi GH; Ma JL; Zhang Q; Zhao ML; Dong HJ
Chin Med J (Engl); 1981 Oct; 94(10):663-8. PubMed ID: 6274591
[No Abstract] [Full Text] [Related]
53. [Serological mass survey of nasopharyngeal carcinoma (author's transl)].
Zeng Y; Liu YX; Wei JN; Zhu JS; Cai SL; Wang PZ; Zhong JM; Li RC; Pan WJ; Li EJ; Tan BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Dec; 1(2):123-6. PubMed ID: 233641
[No Abstract] [Full Text] [Related]
54. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
[TBL] [Abstract][Full Text] [Related]
55. [Virologic-serologic diagnosis of nasopharyngeal cancer].
Bornkamm GW
Strahlentherapie Sonderb; 1984; 78():15-21. PubMed ID: 6328701
[No Abstract] [Full Text] [Related]
56. ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virus.
Nadala EC; Tan TM; Wong HM; Ting RC
J Med Virol; 1996 Sep; 50(1):93-6. PubMed ID: 8890046
[TBL] [Abstract][Full Text] [Related]
57. Nasopharyngeal carcinoma. VII. B and T lymphocytes in the circulating blood and in tumour tissue.
Yata J; Desgranges C; De-Thé G; Mourali N; Ellouz R; Tachibana T; Brugere J
Biomedicine; 1974 Jun; 21(6):244-50. PubMed ID: 4374264
[No Abstract] [Full Text] [Related]
58. [Undifferentiated carcinoma of the nasopharynx associated with the Epstein-Barr virus. Diagnostic value of EBV serology].
Souillet G; Maisonneuve J; Lenoir G; Gilly J; Brunat-Mentigny M; Duc H; Hermier M
Pediatrie; 1980 Sep; 35(6):541-4. PubMed ID: 6255403
[No Abstract] [Full Text] [Related]
59. Herpes viruses and oncogenesis.
Klein G
Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
[No Abstract] [Full Text] [Related]
60. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
